ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    An analysis of how smoking affects blood tests and lung function tests


    Dr. K Kalyan Varma, Dr. Prathyusha Yalamanchi R
    JCDR. 2023: 1272-1277

    Abstract

    In both high-income and low-income nations, cigarette smoking is the major cause of premature illness and death. It causes coronary heart disease, chronic obstructive pulmonary disease (in 90% of cases), and lung cancer. In order to encourage adults to quit smoking and reduce their negative impact on their hematological parameters and lung functions, this study is being conducted. Methods: One hundred seemingly healthy adults (50 smokers) between the ages of 30 and 50 were chosen from Mamata hospital outpatients between January 2022 to December 2022. Non-instructional staff members of Mamata Medical College constituted the control group (50 non-smokers). They were asked to give their informed permission. Results: When compared to non-smokers, smokers have impaired lung function and aberrant hematological parameters, including increased Hb, RBC count, TLC, platelet, and ESR levels. PEFR, FVC, FEV1, and the ratio of FEV1/FVC all declined at a much faster rate among smokers. Conclusion: According to our findings, cigarette smokers had abnormalities in their hematological and respiratory tests. The length of time a person has smoked has a substantial impact on their Hb concentration and other metrics. There were alterations in pulmonary functions indicative of peripheral airway narrowing among smokers, and these deteriorated with continuing smoking.

    Description

    » PDF

    Volume & Issue

    Volume 14 Issue 4

    Keywords